LifeMD (NASDAQ:LFMD) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 48.94 percent. This is a 177.78 percent decrease over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $60.172 million which missed the analyst consensus estimate of $62.064 million by 3.05 percent. This is a 12.70 percent increase over sales of $53.393 million the same period last year. Adj. EPS excludes loss on debt extinguishment of $0.03.